| 查看: 323 | 回复: 0 | |||
lubenle至尊木虫 (职业作家)
|
[交流]
FDA认为无证据表明没有心脏病或中风史的人服用阿斯匹灵有预防心脏病发作或中风作用
|
|
Use of Aspirin for Primary Prevention of Heart Attack and Stroke http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm390574.htm FDA认为无证据表明没有心脏病或中风史的人服用阿斯匹灵有预防心脏病发作或中风作用， 但对于有心脏病或中风史的人服用阿斯匹灵有预防再次发作的作用！ [05/02/2014] Cardiovascular disease, including heart disease and stroke, affects tens of millions of people in the United States. Consumers and patients who do not suffer from cardiovascular disease sometimes consider taking aspirin to reduce the possibility of having a heart attack or stroke. Reducing the possibility of having a first heart attack or stroke is called primary prevention. The FDA has reviewed the available data and does not believe the evidence supports the general use of aspirin for primary prevention of a heart attack or stroke. In fact, there are serious risks associated with the use of aspirin, including increased risk of bleeding in the stomach and brain, in situations where the benefit of aspirin for primary prevention has not been established. The available evidence supports the use of aspirin for preventing another heart attack or stroke in patients who have cardiovascular disease or who have already had a heart attack or stroke. Reducing the risk of additional heart attacks or strokes is known as secondary prevention. In patients who have had a cardiovascular event, the known benefits of aspirin for secondary prevention outweigh the risk of bleeding. |
回复此楼» 猜你喜欢
求助新医学教改标书
已经有0人回复
-
刚接触药品出口的萌新，想请教一下，国内一致性评价和药品出口矛盾吗？
已经有0人回复
-
特种医学论文润色/翻译怎么收费?
已经有236人回复
-
请问投稿系统step3 attributes中speciality应该填什么
已经有3人回复
-
意大利卡拉布里亚大学 (The University of Calabria)｜全奖博士/博士后一年交换项目
已经有2人回复
-
意大利米兰理工大学-华南理工大学招收双博士全额奖学金博士
已经有14人回复
-
英国莱斯特大学遗传流行病组博士招生 ( CSC joint PhD scholarships)
已经有1人回复
-
求一株稳定表达GFP荧光的金黄色葡萄球菌，有偿，拜托
已经有0人回复
30